Evaluating exercise capacity in patients with pulmonary hypertension
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
Chinese Pulmonary Vascular Disease Research Group · NCT02061787
This study tests how well treatments like medication or balloon therapy can improve exercise ability in people with pulmonary hypertension.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Ages | 5 Years to 100 Years |
| Sex | All |
| Sponsor | Chinese Pulmonary Vascular Disease Research Group (other) |
| Locations | 1 site (Beijing) |
| Trial ID | NCT02061787 on ClinicalTrials.gov |
What this trial studies
This study evaluates patients diagnosed with pulmonary hypertension, including pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, using cardiopulmonary exercise testing. The assessments are conducted before and after treatment with medical therapy or balloon pulmonary angioplasty. The goal is to determine the effectiveness of these interventions on patients' exercise capacity and overall health outcomes. This observational study aims to provide insights into the management of pulmonary hypertension.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
Not a fit: Patients with pulmonary hypertension due to hypoxia or left heart diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment strategies and outcomes for patients with pulmonary hypertension.
How similar studies have performed: Other studies have shown promise in using cardiopulmonary exercise testing for assessing outcomes in pulmonary hypertension, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * pulmonary arterial hypertension;( WHO1) * chronic thromboembolic pulmonary hypertension; * pulmonary arterial hypertension due to other cause; Exclusion Criteria: * massive hemoptysis; * unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders; * recent recurrent syncope; * pulmonary hypertension due to hypoxia; * pulmonary hypertension due to left heart diseases.
Where this trial is running
Beijing
- center of pulmonary vascular disease, Fuwai hospital — Beijing, China (RECRUITING)
Study contacts
- Study coordinator: Zhihong Liu, Doctor
- Email: zhihongliufuwai@163.com
- Phone: 8601088396590
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension Associated With Schistosomiasis, Pulmonary Arterial Hypertension, balloon pulmonary angioplasty, cardiopulmonary exercise test